WED-092-YI Implementation of enhanced liver fibrosis testing in type 2 diabetes to improve detection of at-risk metabolic dysfunctionassociated steatohepatitis to optimize hepatology referrals: a duke health analysis

Journal of Hepatology 2026

View at publisher

Authors: Maison Furley, Tom Kaminski, Zach Wolf, Artem Boltyenkov, Amreen Dinani

DOI: 10.1016/s0168-8278(26)01644-2

Cited by: 1

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Cardiovascular Disease and Adiposity Diabetes Cardiovascular Risks and Lipoproteins